Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line.
暂无分享,去创建一个
Zhenfeng Duan | Z. Duan | M. Seiden | R. Yusuf | Michael V Seiden | Diana E Lamendola | Rushdia Z Yusuf | D. Lamendola
[1] U. Germann,et al. P-glycoprotein--a mediator of multidrug resistance in tumour cells. , 1996, European journal of cancer.
[2] G. Chrousos,et al. Ligand-Activation of the Adenosine A2a Receptors Inhibits IL-12 Production by Human Monocytes , 2000, The Journal of Immunology.
[3] M. Seiden,et al. TRAG-3, a novel gene, isolated from a taxol-resistant ovarian carcinoma cell line. , 1999, Gene.
[4] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[5] Z. Duan,et al. Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] Chris Cheadle,et al. Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. , 2002, Cancer research.
[7] M. Baggiolini,et al. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. , 1992, Journal of immunology.
[8] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[9] Teresa Guida,et al. The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes. , 2002, Cancer research.
[10] F. Baas,et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[11] C. Harrington,et al. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. , 2000, Physiological genomics.
[12] B. Dörken,et al. The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines , 2002, Oncogene.
[13] P. Törönen,et al. Analysis of gene expression data using self‐organizing maps , 1999, FEBS letters.
[14] X. Li,et al. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. , 2001, Cancer research.
[15] K. Matsushima,et al. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. , 1992, Chemical immunology.
[16] R. Kobayashi,et al. pl9 skp1 and p45 skp2 are essential elements of the cyclin A-CDK2 S phase kinase , 1995, Cell.
[17] A. Butte,et al. Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] E. Prossnitz,et al. The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. , 1997, Pharmacology & therapeutics.
[19] M. Marcelli,et al. Overexpression of BCL-XL Underlies the Molecular Basis for Resistance to Staurosporine-induced Apoptosis in PC-3 Cells , 2001 .
[20] A. Mantovani,et al. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[21] S. Hilsenbeck,et al. Statistical analysis of array expression data as applied to the problem of tamoxifen resistance. , 1999, Journal of the National Cancer Institute.
[22] M. Pagano,et al. Role of the F-box protein Skp2 in lymphomagenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Ting,et al. Taxol-dependent Transcriptional Activation of IL-8 Expression in a Subset of Human Ovarian Cancer , 1996 .
[24] C. Li,et al. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] B. Chabner,et al. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] J. Mesirov,et al. Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. R. Mejillano,et al. Exchangeable GTP binding site of beta-tubulin. Identification of cysteine 12 as the major site of cross-linking by direct photoaffinity labeling. , 1993, The Journal of biological chemistry.
[28] T. Matsuyama,et al. Induction of Macrophage-Inflammatory Protein-3α Gene Expression by TNF-Dependent NF-κB Activation1 , 2002, The Journal of Immunology.
[29] J. Milbrandt,et al. GDNF and neurturin are target-derived factors essential for cranial parasympathetic neuron development. , 2001, Development.
[30] S. Schiffmann,et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor , 1997, Nature.
[31] A. Manning,et al. NF-κB as a primary regulator of the stress response , 1999, Oncogene.
[32] J. Reed,et al. High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells. , 1994, Leukemia.
[33] H. Friess,et al. Detection and localization of MIP‐3α/LARC/exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer , 1999 .
[34] K. Swenerton,et al. A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy. , 2002, Gynecologic oncology.
[35] R. Strieter,et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.
[36] J. Haines,et al. A genetic linkage map of the long arm of human chromosome 22. , 1989, Genomics.
[37] Yusuke Nakamura,et al. An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. , 2002, Cancer research.
[38] D. Botstein,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[39] K. Matsushima,et al. Interleukin-8 and MCAF: Novel Leukocyte Recruitment and Activating Cytokines (Part 1 of 2) , 1992 .
[40] Wan-Wan Lin,et al. Inhibition of Interleukin-1β-induced NF-κB Activation by Calcium/Calmodulin-dependent Protein Kinase Kinase Occurs through Akt Activation Associated with Interleukin-1 Receptor-associated Kinase Phosphorylation and Uncoupling of MyD88* , 2002, The Journal of Biological Chemistry.
[41] J. Mizuguchi,et al. Bcl-xL confers multi-drug resistance in several squamous cell carcinoma cell lines , 2002 .
[42] K. Anderson,et al. Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonucleotide arrays , 2002, Oncogene.
[43] M. Santoro,et al. Molecular Mechanisms of RET Activation in Human Cancer , 2002, Annals of the New York Academy of Sciences.
[44] S. Cannistra,et al. BAX expression is associated with enhanced intracellular accumulation of paclitaxel: a novel role for BAX during chemotherapy-induced cell death. , 1998, Cancer research.
[45] G. Sherlock. Analysis of large-scale gene expression data. , 2000, Current opinion in immunology.
[46] M. Kunkel,et al. cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. , 2001, The Journal of pharmacology and experimental therapeutics.
[47] G. Viglietto,et al. Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27kip 1 , 2002, Oncogene.
[48] C. Gilks,et al. Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein , 1993, Molecular and cellular biology.
[49] S R Gullans,et al. DNA microarray analysis of complex biologic processes. , 2001, Journal of the American Society of Nephrology : JASN.
[50] Z. Duan,et al. Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells. , 2002, Cytokine.
[51] C. Kunsch,et al. Isolation of cDNA Clones Encoding Eight Different Human G Protein γ Subunits, Including Three Novel Forms Designated the γ4, γ10, and γ11 Subunits (*) , 1995, The Journal of Biological Chemistry.
[52] Teuvo Kohonen,et al. Self-Organizing Maps , 2010 .
[53] A. Mantovani,et al. Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. , 1990, Biochemical and biophysical research communications.
[54] David Y. Thomas,et al. Population genomics of drug resistance in Candida albicans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[55] D. Lambert,et al. Vasodilator responses to adenosine and hyperemia are mediated by A(1) and A(2) receptors in the cat vascular bed. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[56] E. Lees,et al. A Novel Growth- and Cell Cycle-Regulated Protein, ASK, Activates Human Cdc7-Related Kinase and Is Essential for G1/S Transition in Mammalian Cells , 1999, Molecular and Cellular Biology.
[57] U. Matulonis,et al. Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. , 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[58] A. Mantovani,et al. Cloning and Characterization of a Specific Receptor for the Novel CC Chemokine MIP-3α from Lung Dendritic Cells , 1997, The Journal of experimental medicine.
[59] B. Sikic,et al. Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] Z. Cao,et al. IRAK: A Kinase Associated with the Interleukin-1 Receptor , 1996, Science.
[61] J. Díaz,et al. Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition. , 1993, Biochemistry.
[62] E. Mandelkow,et al. The GTP-binding peptide of beta-tubulin. Localization by direct photoaffinity labeling and comparison with nucleotide-binding proteins. , 1988, The Journal of biological chemistry.
[63] J. Mesirov,et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[64] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.